Skip to main content

Cochlear Implants

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Advanced Bionics
Advanced BionicsCA - Valencia
2 programs
CROS Device - Naída CROSN/A
Naída CROSN/A1 trial
Active Trials
NCT03078920Completed13Est. Jul 2017
Cochlear
CochlearAustralia - Macquarie Park
1 program
remote CI programmingN/A1 trial
Active Trials
NCT04721327Completed30Est. Jun 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Cochlearremote CI programming
Advanced BionicsNaída CROS

Clinical Trials (2)

Total enrollment: 43 patients across 2 trials

NCT04721327Cochlearremote CI programming

Remote Care: The Future of Cochlear Implants

Start: Mar 2021Est. completion: Jun 202330 patients
N/ACompleted

Benefits of a Contralateral Routing of Signals (CROS) System in Unilateral CI-recipients

Start: Mar 2017Est. completion: Jul 201713 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.